To clarify the roles of subclasses of α
1-adrenoreceptors in ischemic-reperfused myocardium, we compared the effect of the nonselective α
1-blocker bunazosin with that of the α
1A-blocker WB4101 and the α
1B-blocker chlorethylclonidine (CEC) in isolated rat hearts. After 30 min of preperfusion, Langendorff-perfused hearts were subjected to 25 min of global ischemia followed by 30 min of reperfusion. Hearts were randomly divided into 4 groups, with one of the following substances being added to the perfusate: buffer alone (control), 10
-6 mol/L bunazosin, 10
-7 mol/L WB4101, or 10
-7 mol/L CEC. Bunazosin had a negative inotropic effect and preserved the postischemic ATP content, reduced the postischemic increase in intracellular Na
+ content and then enhanced postreperfusion recovery of creatine phosphate. Bunazosin also reduced myocardial
45Ca
2+ uptake during reperfusion (control 5.2 vs bunazosin 2.5 μmol/g dry weight of tissue (dwt), p<0.01). However, the recovery of left ventricular developed pressure (DP) was not improved when bunazosin was added to the perfusate during reperfusion. WB4101 had neither a negative inotropic nor an energy-sparing effect, but it improved the recovery of DP (control 43% vs WB4101 56% of preischemic value, p<0.05) with no reduction in myocardial
45Ca
2+ uptake. CEC had a negative inotropic and energy-sparing effect and then reduced myocardial
45Ca
2+ uptake (CEC 3.1 μmol/g dwt, p<0.05), but it did not improve the recovery of DP. These results suggest that the preischemic administration of an α
1B-adrenoreceptor subtype blocker protected ischemic-reperfused myocardium via reduction of Ca
2+ overload, whereas the selective blockade of the α
1A-adrenoreceptor subtype reduced myocardial damage via mechanism(s) other than Ca
2+ metabolism. (
Jpn Circ J 1997;
61: 927 - 935)
抄録全体を表示